We sincerely welcome Dr. Cameron K. Tebbi from Florida Pediatric Hematology/Oncology and Children's Cancer Research Group Laboratory, USA, to join the Editorial Board of OBM Genetics. Dr. Cameron K. Tebbi is an expert in pediatric cancer. He has many years of research and teaching experience in the area of pediatric hematology and oncology. He has several patents, edited two books, and has more than 300 publications. We appreciate Dr. Cameron K. Tebbi for his participation and support.
We sincerely welcome Prof. Dr. Pedro Martínez-Gómez, from CEBAS-CSIC, Spain, to join the Editorial Board of OBM Genetics. He is an international reference in Prunus Breeding and Biotechnology including Genetics, Genomics, Transcriptomics and epigenetics with more than 150 papers published in international journals included in the Web of Science. He also has 5 new apricot varieties, 4 new almond varieties and 1 new Japanese plum variety widely cultivated in Spain and Southern Europe where more than 5 M trees from these varieties are grown at this moment. In addition, he has been coordinator of 22 projects at the regional, national and international levels, as well as participating in 30 other projects and agreements with companies as a member of the research team. Throughout his research career he has participated in the scientific training of more than 70 students and researchers from 20 different nationalities. He has supervised 18 PhD Theses. Most of their former graduate doctors are, at this moment, junior and senior researchers around the world. In August 2006 received in Seoul (Korea) the "Miklos Faust International Award", an International Award of the American Society for Horticultural Science (ASHS) and the International Society for Horticultural Science (ISHS) for its contribution to the international fruit science research. In January 2012 he received in Teheran (Iran) the “Khwarizmi International Award” organized by the Iranian Research Organization for Science and Technology (IROST) and the “FAO Medal Award” from the Food and Agriculture Organization for his contribution to the application of biotechnology tolls in the development of the fruit research in developing countries. In January of 2019, received in La Havana (Cuba), the “CITMA Award 2018” for their collaboration in the conservation of plant genetic resources in Cuba. We appreciate Prof. Martínez-Gómez for his participation and support.
We sincerely welcome Prof. Dr. Fabrizio Stasolla, from "Giustino Fortunato" University of Benevento, Italy, to join the Editorial Board of OBM Genetics. Prof. Stasolla is an Associate Professor of Developmental Psychology at “Giustino Fortunato” University of Benevento (Italy). His interests deal with assistive technology-based programs and rehabilitative interventions to promote an active role, independence, and self-determination in individuals with neurological disorders and severe to profound and multiple disabilities. Additionally, he is interested in aided-alternative and augmentative communication strategies to support communication skills in non-verbal individuals. Recently, he fits virtual reality setups, new and wearable technologies, a. nd telerehabilitation for both assessment and recovery purposes in persons with neurodevelopmental disorders and neurodegenerative diseases. Furthermore, patients with acquired brain injuries either in a vegetative state, in a minimally conscious state or emerging/emerged from it are usually targeted along his research’ interests. Children with attention deficits hyperactivity disorders, autism spectrum disorders, cerebral palsy, rare genetic diseases, Alzheimer or Parkinson diseases, amyotrophic lateral sclerosis or lateral sclerosis are finally included. On that specific topic, he authored several international papers published in peer-reviewed Journals. He also edited “Understanding Children with Cerebral Palsy” (NOVA Publisher, 2020), Rett Syndrome: from diagnosis to treatment (NOVA Publisher, 2021, Fragile X syndrome: from Diagnosis to Treatment (NOVA Publisher, 2022), and recently edited a new IGI Global volume entitled “Assistive Technologies for assessment and recovery of neurological impairments”. Recently he is a Principal Investigator in different projects on new technologies mediated by augmented, virtual, and extended realities, serious games, and telerehabilitation. Finally, he is an Associate Editor for Technologies (MDPI Journals), and Frontiers in Psychology (Neuropsychology Section). Currently, he is in the process of editing a new article collection (as Guest Editor) on the Integration of the Technology in Clinical Settings for Frontiers in Psychology, Section of Psychology in Clinical Settings, and on An Interdisciplinary Approach Towards a Greater Understanding of the Quality of Life in Chronic Mental Illness for Frontiers in Psychiatry, Section of Social Psychiatric and Psychiatric Rehabilitation.. We appreciate Prof. Stasolla for his participation and support.
We sincerely welcome Dr. Masahiro Sato, from National Center for Child Health and Development (NCCHD), Japan, to join the Editorial Board of OBM Genetics. He obtained his PhD in Biochemistry from the Kagoshima University School of Medicine, and later spent ten years at the Laboratory for Pathobiology, Pharma Research Laboratories, Hoechst Japan Ltd. (Kawagoe, Saitama, Japan), where he produced disease mouse models for Alzheimer’s disease and osteoporosis. In April 1996 - March 2006, he spent at the Department of Molecular Life Science, Tokai University School of Medicine (Isehara, Kanagawa, Japan) as Professor (Assistant), where he engaged in developing novel technologies, as exemplified by cell-lineage analysis in mammals using Cre-loxP system and testis-mediated gene transfer (TMGT), a technique without using microinjection-based transgenesis. In April 2006 - March 2021, he spent at the Gene Expression Regulation Section, Frontier Science Research Center, Kagoshima University (Kagoshima, Japan) as Professor, where he engaged in developing novel technologies related to reproduction and molecular biology as well as producing genetically modified piglets suitable for xenotransplantation. Notably, during these periods, he and his colleague Prof. Masato Ohtsuka (Tokai University School of Medicine) succeeded in developing i-GONAD, a novel method for creating genome-edited animals through in vivo genome editing. In April 2021 – Present, he is studying reproduction engineering-related research at NCCHD as Senior Fellow. We appreciate Dr. Masahiro Sato for his participation and support.
We sincerely welcome Professor Ying S. Zou from Johns Hopkins University, USA, to join the Editorial Board of OBM Genetics. Her areas of clinical expertise include the diagnosis of genetic abnormalities in patients with cancer or congenital diseases. Dr. Zou serves as Director of the Cytogenetics and Cytogenomics Laboratory at The Johns Hopkins Hospital, Director of the Cancer Cytogenetics Laboratory, Director of Cytogenomic Research Core, and Associate Director of Molecular Diagnostics Laboratory, Johns Hopkins Genomics. She is interested in the development of clinical cytogenomic and molecular genetics laboratory tests that can be used in the clinical setting for better patient care, personalized medicine, as well as for discovering disease variants and novel cancer biomarkers. As a member of the American Board of Medical Genetics and Genomics, certified in Clinical Cytogenetics and Clinical Molecular Genetics, Dr. Zou is active in the training of residents and fellows in several training programs, as well as students for clinical cytogenetics, molecular genetics, pharmaco-genomics and personalized medicine. She was recognized with The Best Attending Pathologist Teacher in Clinical Pathology by University of Maryland in 2017-2018. She is an active committee member of professional societies such as American College of Medical Genetics and Genomics (ACMG), Association for Molecular Pathology (AMP), College of American Pathologists (CAP), Cancer Genomics Consortium (CGC), and Association of Genetic Technologists (AGT), etc., as well as an editor, board member, and associate editor for several professorial journals. We appreciate Professor Zou for her participation and support.
We sincerely welcome Prof. Bruce O'Hara, from the University of Kentucky, USA, to join the Editorial Board of OBM Genetics. He obtained his PhD in Human and Mammalian Genetics from The Johns Hopkins School of Medicine, and later spent twelve years at the Stanford University Center for Sleep and Circadian Neurobiology where he established a research program directed towards an understanding of sleep using higher throughput behavioral and genomic methodologies. He currently has over 35 years of experience in mammalian genetics and especially mouse models of human disease, and has over 95 publications in areas ranging from the effects of drugs to large-scale genetic screens and models of neurodegenerative disorders. We appreciate Dr. O'Hara for his participation and support.
We sincerely welcome Prof. Yuri Shavrukov, from Flinders University, Australia, to join the Editorial Board of OBM Genetics. Originally, Prof. Shavrukov worked at the Institute of Cytology and Genetics, Russian Academy of Sciences, Novosibirsk (Russia), where he received his PhD degree (1991). In 2001, he was selected and employed by CSIRO (Commonwealth Scientific and Industrial Research Organisation), Adelaide, Australia. After CSIRO, he received a position at the University of Adelaide, Plant Genomics Centre (2005-2016), and since that he moved to Flinders University, Adelaide. Currently, Prof. Yuri Shavrukov is working at Flinders University with some collaborative international research projects. His research interests include plant genetics and genomics, gene structure and expression analysis in plants, development and application of molecular markers in plant biology. We appreciate Prof. Shavrukov for his participation and support.
We sincerely welcome Dr. Mohan Shri Jain from University of Helsinki, Finland, to join the Editorial Board of OBM Genetics. He received his M. Phil, 1973 and Ph.D., 1978, Jawaharlal Nehru University, New Delhi, India. He was a postdoctoral fellow in Israel, USA, and visiting Professor in Japan, Malaysia, Germany, and Italy. He was a Technical Officer at, International Atomic Energy Agency (IAEA), Vienna, Austria, from 1999-to 2005. He is on the Editorial Board and a reviewer in several well-reputed journals. His publications are over 170 in peer-reviewed journals, book chapters, and conference proceedings, and edited 68 books; invited speakers, and acted as a chairperson in several international conferences worldwide. In commemoration of the awarding IAEA of the Nobel Peace Prize in 2005, as a team member, he received this certificate; consultant to IAEA, the European Union, The Government of Grenada, and the Egyptian Government. His current research interests are on in vitro techniques, mutagenesis, transgenics, genetic diversity and conservation, climate change, and food security. We appreciate Dr. Jain for his participation and support.
We sincerely welcome Dr. Paola Ungaro, from National Research Council, Italy, to join the Editorial Board of OBM Genetics. Dr. Ungaro is a Researcher at the National Research Council (CNR) in Institute for Experimental Endocrinology and Oncology “Gaetano Salvatore” of Naples, Italy. Dr Ungaro’s research interest includes epigenetic and transcriptional regulation of obesity and diabetes related genes and epigenetic regulation by natural compounds. The research activity includes three main research lines: 1. Evaluation of the effects of High-Fat Diet (HFD) on the expression of genes codifying for enzymes known to induce histone post-translational modifications (PTMs). 2. Study of the effects of Polyphenols on the epigenetic regulation of obesity-related genes and on the expression of key enzyme involved in chromatin remodelling. 3. Study of the effects of Polyphenols on the expression of genes involved in the browning of white adipose tissue. We appreciate Dr. Ungaro for her participation and support.
We sincerely welcome Prof. Dr. Yan Sanders, from University of Alabama at Birmingham, United States, to join the Editorial Board of OBM Genetics. Dr. Sanders is currently Associate Professor of Medicine. Her main research interests are epigenetic mechanisms in tissue injury, repair and aging. Her ongoing projects include exploring epigenetic alterations in pulmonary fibrosis, examining the effects of histone modifier on fibrotic lung fibroblasts, determining the epigenetic mechanisms of cellular senescence, aging, and age-related chronic diseases, specifically histone modifications and DNA methylation. We appreciate Prof. Sanders for her participation and support.